A Multi-Center Clinical Trial To Evaluate Chinese Herbal Medicines in the Treatment of Severe Hand-foot-mouth Disease
- Conditions
- Hand, Foot and Mouth Disease
- Interventions
- Drug: Western therapyDrug: Herbal concentrate-granules plus western therapyDrug: Reduning Injection plus western therapy
- Registration Number
- NCT01145664
- Lead Sponsor
- Beijing YouAn Hospital
- Brief Summary
The aim of this study is to evaluate the effectiveness and safety of Chinese herbal medicines for severe hand-foot-mouth disease.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 390
- Clinical diagnosis of severe hand-foot-mouth disease patients according to hand-foot-mouth disease treatment guidelines 2010 issued by China's Ministry of Health
- not more than 24 hours of occurrence of severe symptoms
- age of 1-13 years
- Patients or their guardians agree to participate in this study and signed the informed consent form
- Suffering from neurogenic pulmonary edema, heart or lung failure.
- Complicated with other serious diseases such as chronic hepatitis, congenital heart disease, acute or chronic nephritis and blood diseases, etc
- the history of allergies on Chinese medicine
- the history of mild increase of blood bilirubin hemolysis (or uric bravery former positive) phenomenon
- using hormonal therapy
- Attending other clinical studies on hand-foot-mouth disease
- Patients or their guardians suffering from mental illness
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Western therapy Western therapy - Herbal concentrate-granules plus western therapy Herbal concentrate-granules plus western therapy - Reduning Injection plus western therapy Reduning Injection plus western therapy -
- Primary Outcome Measures
Name Time Method incidence of complications 15 days incidence of critically ill patients 15 days
- Secondary Outcome Measures
Name Time Method case fatality rate 15 days time of symptom disappearance 15 days time of bringing down a fever 15 days length of stay 15 days dose and usage of hormones 15 days safety outcome(adverse effects) 15 days
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (6)
Guangzhou Women and Children Hospital
🇨🇳Guangzhou, Guangdong, China
The First Affiliated Hospital of Guangxi Medical University
🇨🇳Nanning, Guangxi, China
Kaifeng Municipal Children's Hospital
🇨🇳Kaifeng, Henan, China
Hunan Provincial Children's Hospital
🇨🇳Changsha, Hunan, China
Anhui Provincial Children's Hospital
🇨🇳Anhui, China
Beijing YouAn Hospital,Capital Medical University
🇨🇳Beijing, China
Guangzhou Women and Children Hospital🇨🇳Guangzhou, Guangdong, ChinaYi XuSub Investigator